Global Smart Syringe

Smart Syringe Comprehensive Study by Type (Auto Disable (AD), Passive Safety, Active Safety), Application (Vaccination, Drug Delivery, Blood Specimen Collection), End Users (Hospitals, Diabetic Patients, Psychiatrics, Others) Players and Region - Global Market Outlook to 2026

Smart Syringe Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Smart Syringe Market Scope?
Smart syringes can be defined as medical devices that are made with safety mechanisms to prevent the reuse of syringes and regulate unsafe injection practices. They are prepared with features to avoid needle stick injuries in the person who uses these syringes and prevent transmission of blood-borne diseases and life-threatening infections such as with HIV, hepatitis and other diseases. The prime end users of are hospitals and health maintenance organizations (HMOs), psychiatrists, and diabetic patients. These syringes are used in vaccination, drug delivery and blood specimen collection.

The Smart Syringe market study is being classified by Type (Auto Disable (AD), Passive Safety and Active Safety), by Application (Vaccination, Drug Delivery and Blood Specimen Collection) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Smart Syringe market throughout the predicted period.

Becton Dickinson (United States), Cardinal Health (United States), B. Braun Melsungen AG (Germany), Smiths Group plc (United Kingdom), Gerresheimer AG (Germany), Retractable Technologies, Inc. (United States), L.O.M. Medical International (Canada), ARxIUM (Canada), Medtronic Plc (Ireland) and Terumo Medical (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Smart Syringe market by Type, Application and Region.

On the basis of geography, the market of Smart Syringe has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
January 8, 2019: Cardinal Health acquires Mirixa Corporation. This expanded portfolio from Cardinal Health will bring payers an enhanced pharmacy services network and will standardize care delivery, documentation and billing for MTM services.
Jan 24, 2019: BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique. BD Nano 2nd gen pen needles help mitigate the risks resulting from user injection force variability through its contoured needle base and compensate for variable injection forces by first concentrating.
WHO calls for worldwide use of "smart" syringes. New WHO injection safety guidelines and policy released today provide detailed recommendations highlighting the value of safety features for syringes, including devices that protect health workers against accidental needle injury and consequent exposure to infection. WHO also stresses the need to reduce the number of unnecessary injections as a critical way of reducing risk.

Influencing Market Trend
  • Advancements in Technology
  • Growing Trend of Safe Injection Practices in Medical and Health-Care Systems

Market Drivers
  • High Prevalence of Blood-Borne Transmission Such as Hepatitis B, C and HIV
  • Growth in Adoption of Safety Syringes

Opportunities
  • Mandatory Recommendation by WHO to Switch to Smart Syringes
  • High Level of Unmet Needs in Emerging Economies

Restraints
  • High Cost of Passive Safety Syringes
  • Availability of Alternative Drug Delivery Methods

Challenges
  • Low Awareness in Developing Economies


Key Target Audience
Manufacturers of Smart Syringe, Suppliers of Smart Syringe, Wholesalers, Distributers and Retailers of Smart Syringe, Healthcare Industry, Research Organizations and Governmental Bodies

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Auto Disable (AD)
  • Passive Safety
  • Active Safety
By Application
  • Vaccination
  • Drug Delivery
  • Blood Specimen Collection
By End Users
  • Hospitals
  • Diabetic Patients
  • Psychiatrics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Blood-Borne Transmission Such as Hepatitis B, C and HIV
      • 3.2.2. Growth in Adoption of Safety Syringes
    • 3.3. Market Challenges
      • 3.3.1. Low Awareness in Developing Economies
    • 3.4. Market Trends
      • 3.4.1. Advancements in Technology
      • 3.4.2. Growing Trend of Safe Injection Practices in Medical and Health-Care Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smart Syringe, by Type, Application, End Users and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Smart Syringe (Value)
      • 5.2.1. Global Smart Syringe by: Type (Value)
        • 5.2.1.1. Auto Disable (AD)
        • 5.2.1.2. Passive Safety
        • 5.2.1.3. Active Safety
      • 5.2.2. Global Smart Syringe by: Application (Value)
        • 5.2.2.1. Vaccination
        • 5.2.2.2. Drug Delivery
        • 5.2.2.3. Blood Specimen Collection
      • 5.2.3. Global Smart Syringe by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diabetic Patients
        • 5.2.3.3. Psychiatrics
        • 5.2.3.4. Others
      • 5.2.4. Global Smart Syringe Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Smart Syringe (Volume)
      • 5.3.1. Global Smart Syringe by: Type (Volume)
        • 5.3.1.1. Auto Disable (AD)
        • 5.3.1.2. Passive Safety
        • 5.3.1.3. Active Safety
      • 5.3.2. Global Smart Syringe by: Application (Volume)
        • 5.3.2.1. Vaccination
        • 5.3.2.2. Drug Delivery
        • 5.3.2.3. Blood Specimen Collection
      • 5.3.3. Global Smart Syringe by: End Users (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Diabetic Patients
        • 5.3.3.3. Psychiatrics
        • 5.3.3.4. Others
      • 5.3.4. Global Smart Syringe Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Smart Syringe (Price)
      • 5.4.1. Global Smart Syringe by: Type (Price)
  • 6. Smart Syringe: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cardinal Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Smiths Group plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Gerresheimer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Retractable Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. L.O.M. Medical International (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ARxIUM (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic Plc (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Smart Syringe Sale, by Type, Application, End Users and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Smart Syringe (Value)
      • 7.2.1. Global Smart Syringe by: Type (Value)
        • 7.2.1.1. Auto Disable (AD)
        • 7.2.1.2. Passive Safety
        • 7.2.1.3. Active Safety
      • 7.2.2. Global Smart Syringe by: Application (Value)
        • 7.2.2.1. Vaccination
        • 7.2.2.2. Drug Delivery
        • 7.2.2.3. Blood Specimen Collection
      • 7.2.3. Global Smart Syringe by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diabetic Patients
        • 7.2.3.3. Psychiatrics
        • 7.2.3.4. Others
      • 7.2.4. Global Smart Syringe Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Smart Syringe (Volume)
      • 7.3.1. Global Smart Syringe by: Type (Volume)
        • 7.3.1.1. Auto Disable (AD)
        • 7.3.1.2. Passive Safety
        • 7.3.1.3. Active Safety
      • 7.3.2. Global Smart Syringe by: Application (Volume)
        • 7.3.2.1. Vaccination
        • 7.3.2.2. Drug Delivery
        • 7.3.2.3. Blood Specimen Collection
      • 7.3.3. Global Smart Syringe by: End Users (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Diabetic Patients
        • 7.3.3.3. Psychiatrics
        • 7.3.3.4. Others
      • 7.3.4. Global Smart Syringe Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Smart Syringe (Price)
      • 7.4.1. Global Smart Syringe by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smart Syringe: by Type(USD Million)
  • Table 2. Smart Syringe Auto Disable (AD) , by Region USD Million (2015-2020)
  • Table 3. Smart Syringe Passive Safety , by Region USD Million (2015-2020)
  • Table 4. Smart Syringe Active Safety , by Region USD Million (2015-2020)
  • Table 5. Smart Syringe: by Application(USD Million)
  • Table 6. Smart Syringe Vaccination , by Region USD Million (2015-2020)
  • Table 7. Smart Syringe Drug Delivery , by Region USD Million (2015-2020)
  • Table 8. Smart Syringe Blood Specimen Collection , by Region USD Million (2015-2020)
  • Table 9. Smart Syringe: by End Users(USD Million)
  • Table 10. Smart Syringe Hospitals , by Region USD Million (2015-2020)
  • Table 11. Smart Syringe Diabetic Patients , by Region USD Million (2015-2020)
  • Table 12. Smart Syringe Psychiatrics , by Region USD Million (2015-2020)
  • Table 13. Smart Syringe Others , by Region USD Million (2015-2020)
  • Table 14. South America Smart Syringe, by Country USD Million (2015-2020)
  • Table 15. South America Smart Syringe, by Type USD Million (2015-2020)
  • Table 16. South America Smart Syringe, by Application USD Million (2015-2020)
  • Table 17. South America Smart Syringe, by End Users USD Million (2015-2020)
  • Table 18. Brazil Smart Syringe, by Type USD Million (2015-2020)
  • Table 19. Brazil Smart Syringe, by Application USD Million (2015-2020)
  • Table 20. Brazil Smart Syringe, by End Users USD Million (2015-2020)
  • Table 21. Argentina Smart Syringe, by Type USD Million (2015-2020)
  • Table 22. Argentina Smart Syringe, by Application USD Million (2015-2020)
  • Table 23. Argentina Smart Syringe, by End Users USD Million (2015-2020)
  • Table 24. Rest of South America Smart Syringe, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Smart Syringe, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Smart Syringe, by End Users USD Million (2015-2020)
  • Table 27. Asia Pacific Smart Syringe, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Smart Syringe, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Smart Syringe, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Smart Syringe, by End Users USD Million (2015-2020)
  • Table 31. China Smart Syringe, by Type USD Million (2015-2020)
  • Table 32. China Smart Syringe, by Application USD Million (2015-2020)
  • Table 33. China Smart Syringe, by End Users USD Million (2015-2020)
  • Table 34. Japan Smart Syringe, by Type USD Million (2015-2020)
  • Table 35. Japan Smart Syringe, by Application USD Million (2015-2020)
  • Table 36. Japan Smart Syringe, by End Users USD Million (2015-2020)
  • Table 37. India Smart Syringe, by Type USD Million (2015-2020)
  • Table 38. India Smart Syringe, by Application USD Million (2015-2020)
  • Table 39. India Smart Syringe, by End Users USD Million (2015-2020)
  • Table 40. South Korea Smart Syringe, by Type USD Million (2015-2020)
  • Table 41. South Korea Smart Syringe, by Application USD Million (2015-2020)
  • Table 42. South Korea Smart Syringe, by End Users USD Million (2015-2020)
  • Table 43. Taiwan Smart Syringe, by Type USD Million (2015-2020)
  • Table 44. Taiwan Smart Syringe, by Application USD Million (2015-2020)
  • Table 45. Taiwan Smart Syringe, by End Users USD Million (2015-2020)
  • Table 46. Australia Smart Syringe, by Type USD Million (2015-2020)
  • Table 47. Australia Smart Syringe, by Application USD Million (2015-2020)
  • Table 48. Australia Smart Syringe, by End Users USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Smart Syringe, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Smart Syringe, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Smart Syringe, by End Users USD Million (2015-2020)
  • Table 52. Europe Smart Syringe, by Country USD Million (2015-2020)
  • Table 53. Europe Smart Syringe, by Type USD Million (2015-2020)
  • Table 54. Europe Smart Syringe, by Application USD Million (2015-2020)
  • Table 55. Europe Smart Syringe, by End Users USD Million (2015-2020)
  • Table 56. Germany Smart Syringe, by Type USD Million (2015-2020)
  • Table 57. Germany Smart Syringe, by Application USD Million (2015-2020)
  • Table 58. Germany Smart Syringe, by End Users USD Million (2015-2020)
  • Table 59. France Smart Syringe, by Type USD Million (2015-2020)
  • Table 60. France Smart Syringe, by Application USD Million (2015-2020)
  • Table 61. France Smart Syringe, by End Users USD Million (2015-2020)
  • Table 62. Italy Smart Syringe, by Type USD Million (2015-2020)
  • Table 63. Italy Smart Syringe, by Application USD Million (2015-2020)
  • Table 64. Italy Smart Syringe, by End Users USD Million (2015-2020)
  • Table 65. United Kingdom Smart Syringe, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Smart Syringe, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Smart Syringe, by End Users USD Million (2015-2020)
  • Table 68. Netherlands Smart Syringe, by Type USD Million (2015-2020)
  • Table 69. Netherlands Smart Syringe, by Application USD Million (2015-2020)
  • Table 70. Netherlands Smart Syringe, by End Users USD Million (2015-2020)
  • Table 71. Rest of Europe Smart Syringe, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Smart Syringe, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Smart Syringe, by End Users USD Million (2015-2020)
  • Table 74. MEA Smart Syringe, by Country USD Million (2015-2020)
  • Table 75. MEA Smart Syringe, by Type USD Million (2015-2020)
  • Table 76. MEA Smart Syringe, by Application USD Million (2015-2020)
  • Table 77. MEA Smart Syringe, by End Users USD Million (2015-2020)
  • Table 78. Middle East Smart Syringe, by Type USD Million (2015-2020)
  • Table 79. Middle East Smart Syringe, by Application USD Million (2015-2020)
  • Table 80. Middle East Smart Syringe, by End Users USD Million (2015-2020)
  • Table 81. Africa Smart Syringe, by Type USD Million (2015-2020)
  • Table 82. Africa Smart Syringe, by Application USD Million (2015-2020)
  • Table 83. Africa Smart Syringe, by End Users USD Million (2015-2020)
  • Table 84. North America Smart Syringe, by Country USD Million (2015-2020)
  • Table 85. North America Smart Syringe, by Type USD Million (2015-2020)
  • Table 86. North America Smart Syringe, by Application USD Million (2015-2020)
  • Table 87. North America Smart Syringe, by End Users USD Million (2015-2020)
  • Table 88. United States Smart Syringe, by Type USD Million (2015-2020)
  • Table 89. United States Smart Syringe, by Application USD Million (2015-2020)
  • Table 90. United States Smart Syringe, by End Users USD Million (2015-2020)
  • Table 91. Canada Smart Syringe, by Type USD Million (2015-2020)
  • Table 92. Canada Smart Syringe, by Application USD Million (2015-2020)
  • Table 93. Canada Smart Syringe, by End Users USD Million (2015-2020)
  • Table 94. Mexico Smart Syringe, by Type USD Million (2015-2020)
  • Table 95. Mexico Smart Syringe, by Application USD Million (2015-2020)
  • Table 96. Mexico Smart Syringe, by End Users USD Million (2015-2020)
  • Table 97. Smart Syringe Sales: by Type(K Units)
  • Table 98. Smart Syringe Sales Auto Disable (AD) , by Region K Units (2015-2020)
  • Table 99. Smart Syringe Sales Passive Safety , by Region K Units (2015-2020)
  • Table 100. Smart Syringe Sales Active Safety , by Region K Units (2015-2020)
  • Table 101. Smart Syringe Sales: by Application(K Units)
  • Table 102. Smart Syringe Sales Vaccination , by Region K Units (2015-2020)
  • Table 103. Smart Syringe Sales Drug Delivery , by Region K Units (2015-2020)
  • Table 104. Smart Syringe Sales Blood Specimen Collection , by Region K Units (2015-2020)
  • Table 105. Smart Syringe Sales: by End Users(K Units)
  • Table 106. Smart Syringe Sales Hospitals , by Region K Units (2015-2020)
  • Table 107. Smart Syringe Sales Diabetic Patients , by Region K Units (2015-2020)
  • Table 108. Smart Syringe Sales Psychiatrics , by Region K Units (2015-2020)
  • Table 109. Smart Syringe Sales Others , by Region K Units (2015-2020)
  • Table 110. South America Smart Syringe Sales, by Country K Units (2015-2020)
  • Table 111. South America Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 112. South America Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 113. South America Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 114. Brazil Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 115. Brazil Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 116. Brazil Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 117. Argentina Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 118. Argentina Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 119. Argentina Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 120. Rest of South America Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 121. Rest of South America Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 122. Rest of South America Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 123. Asia Pacific Smart Syringe Sales, by Country K Units (2015-2020)
  • Table 124. Asia Pacific Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 125. Asia Pacific Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 126. Asia Pacific Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 127. China Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 128. China Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 129. China Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 130. Japan Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 131. Japan Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 132. Japan Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 133. India Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 134. India Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 135. India Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 136. South Korea Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 137. South Korea Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 138. South Korea Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 139. Taiwan Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 140. Taiwan Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 141. Taiwan Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 142. Australia Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 143. Australia Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 144. Australia Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 146. Rest of Asia-Pacific Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 148. Europe Smart Syringe Sales, by Country K Units (2015-2020)
  • Table 149. Europe Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 150. Europe Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 151. Europe Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 152. Germany Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 153. Germany Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 154. Germany Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 155. France Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 156. France Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 157. France Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 158. Italy Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 159. Italy Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 160. Italy Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 161. United Kingdom Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 162. United Kingdom Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 163. United Kingdom Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 164. Netherlands Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 165. Netherlands Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 166. Netherlands Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 167. Rest of Europe Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 168. Rest of Europe Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 169. Rest of Europe Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 170. MEA Smart Syringe Sales, by Country K Units (2015-2020)
  • Table 171. MEA Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 172. MEA Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 173. MEA Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 174. Middle East Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 175. Middle East Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 176. Middle East Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 177. Africa Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 178. Africa Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 179. Africa Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 180. North America Smart Syringe Sales, by Country K Units (2015-2020)
  • Table 181. North America Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 182. North America Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 183. North America Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 184. United States Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 185. United States Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 186. United States Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 187. Canada Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 188. Canada Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 189. Canada Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 190. Mexico Smart Syringe Sales, by Type K Units (2015-2020)
  • Table 191. Mexico Smart Syringe Sales, by Application K Units (2015-2020)
  • Table 192. Mexico Smart Syringe Sales, by End Users K Units (2015-2020)
  • Table 193. Smart Syringe: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Smart Syringe: by Type(USD Million)
  • Table 205. Smart Syringe Auto Disable (AD) , by Region USD Million (2021-2026)
  • Table 206. Smart Syringe Passive Safety , by Region USD Million (2021-2026)
  • Table 207. Smart Syringe Active Safety , by Region USD Million (2021-2026)
  • Table 208. Smart Syringe: by Application(USD Million)
  • Table 209. Smart Syringe Vaccination , by Region USD Million (2021-2026)
  • Table 210. Smart Syringe Drug Delivery , by Region USD Million (2021-2026)
  • Table 211. Smart Syringe Blood Specimen Collection , by Region USD Million (2021-2026)
  • Table 212. Smart Syringe: by End Users(USD Million)
  • Table 213. Smart Syringe Hospitals , by Region USD Million (2021-2026)
  • Table 214. Smart Syringe Diabetic Patients , by Region USD Million (2021-2026)
  • Table 215. Smart Syringe Psychiatrics , by Region USD Million (2021-2026)
  • Table 216. Smart Syringe Others , by Region USD Million (2021-2026)
  • Table 217. South America Smart Syringe, by Country USD Million (2021-2026)
  • Table 218. South America Smart Syringe, by Type USD Million (2021-2026)
  • Table 219. South America Smart Syringe, by Application USD Million (2021-2026)
  • Table 220. South America Smart Syringe, by End Users USD Million (2021-2026)
  • Table 221. Brazil Smart Syringe, by Type USD Million (2021-2026)
  • Table 222. Brazil Smart Syringe, by Application USD Million (2021-2026)
  • Table 223. Brazil Smart Syringe, by End Users USD Million (2021-2026)
  • Table 224. Argentina Smart Syringe, by Type USD Million (2021-2026)
  • Table 225. Argentina Smart Syringe, by Application USD Million (2021-2026)
  • Table 226. Argentina Smart Syringe, by End Users USD Million (2021-2026)
  • Table 227. Rest of South America Smart Syringe, by Type USD Million (2021-2026)
  • Table 228. Rest of South America Smart Syringe, by Application USD Million (2021-2026)
  • Table 229. Rest of South America Smart Syringe, by End Users USD Million (2021-2026)
  • Table 230. Asia Pacific Smart Syringe, by Country USD Million (2021-2026)
  • Table 231. Asia Pacific Smart Syringe, by Type USD Million (2021-2026)
  • Table 232. Asia Pacific Smart Syringe, by Application USD Million (2021-2026)
  • Table 233. Asia Pacific Smart Syringe, by End Users USD Million (2021-2026)
  • Table 234. China Smart Syringe, by Type USD Million (2021-2026)
  • Table 235. China Smart Syringe, by Application USD Million (2021-2026)
  • Table 236. China Smart Syringe, by End Users USD Million (2021-2026)
  • Table 237. Japan Smart Syringe, by Type USD Million (2021-2026)
  • Table 238. Japan Smart Syringe, by Application USD Million (2021-2026)
  • Table 239. Japan Smart Syringe, by End Users USD Million (2021-2026)
  • Table 240. India Smart Syringe, by Type USD Million (2021-2026)
  • Table 241. India Smart Syringe, by Application USD Million (2021-2026)
  • Table 242. India Smart Syringe, by End Users USD Million (2021-2026)
  • Table 243. South Korea Smart Syringe, by Type USD Million (2021-2026)
  • Table 244. South Korea Smart Syringe, by Application USD Million (2021-2026)
  • Table 245. South Korea Smart Syringe, by End Users USD Million (2021-2026)
  • Table 246. Taiwan Smart Syringe, by Type USD Million (2021-2026)
  • Table 247. Taiwan Smart Syringe, by Application USD Million (2021-2026)
  • Table 248. Taiwan Smart Syringe, by End Users USD Million (2021-2026)
  • Table 249. Australia Smart Syringe, by Type USD Million (2021-2026)
  • Table 250. Australia Smart Syringe, by Application USD Million (2021-2026)
  • Table 251. Australia Smart Syringe, by End Users USD Million (2021-2026)
  • Table 252. Rest of Asia-Pacific Smart Syringe, by Type USD Million (2021-2026)
  • Table 253. Rest of Asia-Pacific Smart Syringe, by Application USD Million (2021-2026)
  • Table 254. Rest of Asia-Pacific Smart Syringe, by End Users USD Million (2021-2026)
  • Table 255. Europe Smart Syringe, by Country USD Million (2021-2026)
  • Table 256. Europe Smart Syringe, by Type USD Million (2021-2026)
  • Table 257. Europe Smart Syringe, by Application USD Million (2021-2026)
  • Table 258. Europe Smart Syringe, by End Users USD Million (2021-2026)
  • Table 259. Germany Smart Syringe, by Type USD Million (2021-2026)
  • Table 260. Germany Smart Syringe, by Application USD Million (2021-2026)
  • Table 261. Germany Smart Syringe, by End Users USD Million (2021-2026)
  • Table 262. France Smart Syringe, by Type USD Million (2021-2026)
  • Table 263. France Smart Syringe, by Application USD Million (2021-2026)
  • Table 264. France Smart Syringe, by End Users USD Million (2021-2026)
  • Table 265. Italy Smart Syringe, by Type USD Million (2021-2026)
  • Table 266. Italy Smart Syringe, by Application USD Million (2021-2026)
  • Table 267. Italy Smart Syringe, by End Users USD Million (2021-2026)
  • Table 268. United Kingdom Smart Syringe, by Type USD Million (2021-2026)
  • Table 269. United Kingdom Smart Syringe, by Application USD Million (2021-2026)
  • Table 270. United Kingdom Smart Syringe, by End Users USD Million (2021-2026)
  • Table 271. Netherlands Smart Syringe, by Type USD Million (2021-2026)
  • Table 272. Netherlands Smart Syringe, by Application USD Million (2021-2026)
  • Table 273. Netherlands Smart Syringe, by End Users USD Million (2021-2026)
  • Table 274. Rest of Europe Smart Syringe, by Type USD Million (2021-2026)
  • Table 275. Rest of Europe Smart Syringe, by Application USD Million (2021-2026)
  • Table 276. Rest of Europe Smart Syringe, by End Users USD Million (2021-2026)
  • Table 277. MEA Smart Syringe, by Country USD Million (2021-2026)
  • Table 278. MEA Smart Syringe, by Type USD Million (2021-2026)
  • Table 279. MEA Smart Syringe, by Application USD Million (2021-2026)
  • Table 280. MEA Smart Syringe, by End Users USD Million (2021-2026)
  • Table 281. Middle East Smart Syringe, by Type USD Million (2021-2026)
  • Table 282. Middle East Smart Syringe, by Application USD Million (2021-2026)
  • Table 283. Middle East Smart Syringe, by End Users USD Million (2021-2026)
  • Table 284. Africa Smart Syringe, by Type USD Million (2021-2026)
  • Table 285. Africa Smart Syringe, by Application USD Million (2021-2026)
  • Table 286. Africa Smart Syringe, by End Users USD Million (2021-2026)
  • Table 287. North America Smart Syringe, by Country USD Million (2021-2026)
  • Table 288. North America Smart Syringe, by Type USD Million (2021-2026)
  • Table 289. North America Smart Syringe, by Application USD Million (2021-2026)
  • Table 290. North America Smart Syringe, by End Users USD Million (2021-2026)
  • Table 291. United States Smart Syringe, by Type USD Million (2021-2026)
  • Table 292. United States Smart Syringe, by Application USD Million (2021-2026)
  • Table 293. United States Smart Syringe, by End Users USD Million (2021-2026)
  • Table 294. Canada Smart Syringe, by Type USD Million (2021-2026)
  • Table 295. Canada Smart Syringe, by Application USD Million (2021-2026)
  • Table 296. Canada Smart Syringe, by End Users USD Million (2021-2026)
  • Table 297. Mexico Smart Syringe, by Type USD Million (2021-2026)
  • Table 298. Mexico Smart Syringe, by Application USD Million (2021-2026)
  • Table 299. Mexico Smart Syringe, by End Users USD Million (2021-2026)
  • Table 300. Smart Syringe Sales: by Type(K Units)
  • Table 301. Smart Syringe Sales Auto Disable (AD) , by Region K Units (2021-2026)
  • Table 302. Smart Syringe Sales Passive Safety , by Region K Units (2021-2026)
  • Table 303. Smart Syringe Sales Active Safety , by Region K Units (2021-2026)
  • Table 304. Smart Syringe Sales: by Application(K Units)
  • Table 305. Smart Syringe Sales Vaccination , by Region K Units (2021-2026)
  • Table 306. Smart Syringe Sales Drug Delivery , by Region K Units (2021-2026)
  • Table 307. Smart Syringe Sales Blood Specimen Collection , by Region K Units (2021-2026)
  • Table 308. Smart Syringe Sales: by End Users(K Units)
  • Table 309. Smart Syringe Sales Hospitals , by Region K Units (2021-2026)
  • Table 310. Smart Syringe Sales Diabetic Patients , by Region K Units (2021-2026)
  • Table 311. Smart Syringe Sales Psychiatrics , by Region K Units (2021-2026)
  • Table 312. Smart Syringe Sales Others , by Region K Units (2021-2026)
  • Table 313. South America Smart Syringe Sales, by Country K Units (2021-2026)
  • Table 314. South America Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 315. South America Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 316. South America Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 317. Brazil Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 318. Brazil Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 319. Brazil Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 320. Argentina Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 321. Argentina Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 322. Argentina Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 323. Rest of South America Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 324. Rest of South America Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 325. Rest of South America Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 326. Asia Pacific Smart Syringe Sales, by Country K Units (2021-2026)
  • Table 327. Asia Pacific Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 328. Asia Pacific Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 329. Asia Pacific Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 330. China Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 331. China Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 332. China Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 333. Japan Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 334. Japan Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 335. Japan Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 336. India Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 337. India Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 338. India Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 339. South Korea Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 340. South Korea Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 341. South Korea Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 342. Taiwan Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 343. Taiwan Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 344. Taiwan Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 345. Australia Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 346. Australia Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 347. Australia Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 348. Rest of Asia-Pacific Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 349. Rest of Asia-Pacific Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 350. Rest of Asia-Pacific Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 351. Europe Smart Syringe Sales, by Country K Units (2021-2026)
  • Table 352. Europe Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 353. Europe Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 354. Europe Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 355. Germany Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 356. Germany Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 357. Germany Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 358. France Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 359. France Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 360. France Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 361. Italy Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 362. Italy Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 363. Italy Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 364. United Kingdom Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 365. United Kingdom Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 366. United Kingdom Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 367. Netherlands Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 368. Netherlands Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 369. Netherlands Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 370. Rest of Europe Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 371. Rest of Europe Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 372. Rest of Europe Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 373. MEA Smart Syringe Sales, by Country K Units (2021-2026)
  • Table 374. MEA Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 375. MEA Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 376. MEA Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 377. Middle East Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 378. Middle East Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 379. Middle East Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 380. Africa Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 381. Africa Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 382. Africa Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 383. North America Smart Syringe Sales, by Country K Units (2021-2026)
  • Table 384. North America Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 385. North America Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 386. North America Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 387. United States Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 388. United States Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 389. United States Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 390. Canada Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 391. Canada Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 392. Canada Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 393. Mexico Smart Syringe Sales, by Type K Units (2021-2026)
  • Table 394. Mexico Smart Syringe Sales, by Application K Units (2021-2026)
  • Table 395. Mexico Smart Syringe Sales, by End Users K Units (2021-2026)
  • Table 396. Smart Syringe: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smart Syringe: by Type USD Million (2015-2020)
  • Figure 5. Global Smart Syringe: by Application USD Million (2015-2020)
  • Figure 6. Global Smart Syringe: by End Users USD Million (2015-2020)
  • Figure 7. South America Smart Syringe Share (%), by Country
  • Figure 8. Asia Pacific Smart Syringe Share (%), by Country
  • Figure 9. Europe Smart Syringe Share (%), by Country
  • Figure 10. MEA Smart Syringe Share (%), by Country
  • Figure 11. North America Smart Syringe Share (%), by Country
  • Figure 12. Global Smart Syringe: by Type K Units (2015-2020)
  • Figure 13. Global Smart Syringe: by Application K Units (2015-2020)
  • Figure 14. Global Smart Syringe: by End Users K Units (2015-2020)
  • Figure 15. South America Smart Syringe Share (%), by Country
  • Figure 16. Asia Pacific Smart Syringe Share (%), by Country
  • Figure 17. Europe Smart Syringe Share (%), by Country
  • Figure 18. MEA Smart Syringe Share (%), by Country
  • Figure 19. North America Smart Syringe Share (%), by Country
  • Figure 20. Global Smart Syringe: by Type USD/Units (2015-2020)
  • Figure 21. Global Smart Syringe share by Players 2020 (%)
  • Figure 22. Global Smart Syringe share by Players (Top 3) 2020(%)
  • Figure 23. Global Smart Syringe share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton Dickinson (United States) Revenue: by Geography 2020
  • Figure 27. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cardinal Health (United States) Revenue: by Geography 2020
  • Figure 29. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 31. Smiths Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Smiths Group plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Gerresheimer AG (Germany) Revenue: by Geography 2020
  • Figure 35. Retractable Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Retractable Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. L.O.M. Medical International (Canada) Revenue, Net Income and Gross profit
  • Figure 38. L.O.M. Medical International (Canada) Revenue: by Geography 2020
  • Figure 39. ARxIUM (Canada) Revenue, Net Income and Gross profit
  • Figure 40. ARxIUM (Canada) Revenue: by Geography 2020
  • Figure 41. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Medtronic Plc (Ireland) Revenue: by Geography 2020
  • Figure 43. Terumo Medical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Terumo Medical (United States) Revenue: by Geography 2020
  • Figure 45. Global Smart Syringe: by Type USD Million (2021-2026)
  • Figure 46. Global Smart Syringe: by Application USD Million (2021-2026)
  • Figure 47. Global Smart Syringe: by End Users USD Million (2021-2026)
  • Figure 48. South America Smart Syringe Share (%), by Country
  • Figure 49. Asia Pacific Smart Syringe Share (%), by Country
  • Figure 50. Europe Smart Syringe Share (%), by Country
  • Figure 51. MEA Smart Syringe Share (%), by Country
  • Figure 52. North America Smart Syringe Share (%), by Country
  • Figure 53. Global Smart Syringe: by Type K Units (2021-2026)
  • Figure 54. Global Smart Syringe: by Application K Units (2021-2026)
  • Figure 55. Global Smart Syringe: by End Users K Units (2021-2026)
  • Figure 56. South America Smart Syringe Share (%), by Country
  • Figure 57. Asia Pacific Smart Syringe Share (%), by Country
  • Figure 58. Europe Smart Syringe Share (%), by Country
  • Figure 59. MEA Smart Syringe Share (%), by Country
  • Figure 60. North America Smart Syringe Share (%), by Country
  • Figure 61. Global Smart Syringe: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Becton Dickinson (United States)
  • Cardinal Health (United States)
  • B. Braun Melsungen AG (Germany)
  • Smiths Group plc (United Kingdom)
  • Gerresheimer AG (Germany)
  • Retractable Technologies, Inc. (United States)
  • L.O.M. Medical International (Canada)
  • ARxIUM (Canada)
  • Medtronic Plc (Ireland)
  • Terumo Medical (United States)
Select User Access Type

Key Highlights of Report


Aug 2021 242 Pages 95 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Smart Syringe Quantitative research analysis
Global Smart Syringe Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Smart Syringe market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Smart Syringe market are Becton Dickinson (United States), Cardinal Health (United States), B. Braun Melsungen AG (Germany), Smiths Group plc (United Kingdom), Gerresheimer AG (Germany), Retractable Technologies, Inc. (United States), L.O.M. Medical International (Canada), ARxIUM (Canada), Medtronic Plc (Ireland) and Terumo Medical (United States), to name a few.
In this highly competitive & fast evolving Smart Syringe industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Smart Syringe Report?

Have a Query? Click Here

Other Related Reports

Oxygen Therapy Systems Comprehensive Study by Type (Compressed gas cylinders (Bulk Oxygen, Manifold System), Liquid oxygen (Portable Liquid, Bulk Liquid Oxygen), Transfilling Oxygen Cylinder), Applic...
$ 3750
Transseptal Needle Comprehensive Study by Application (Atrial fibrillation (AF) ablation, Left atrial appendage (LAA) occlusion, Mitral valve repair), End-users (Hospitals, Clinics, Ambulatory Surgic...
$ 3450
Glaucoma Surgical Devices Comprehensive Study by Type (Punches, Forceps, Algerbrush, Probes, Diamond Knives, USC Marker, USC Planner, USC Shaver, Laser System, Glaucoma Drainage Device (Shunts, Stent...
$ 3750
Minimally Invasive Surgical Instruments Comprehensive Study by Type (Electrosurgical Instruments, Handheld Instruments, Inflation Systems, Auxiliary Instruments, Cutter Instruments, Guiding Devices, ...
$ 3750
Fractional Flow Reserve Comprehensive Study by Type (FFR guidewires systems, FFR monitoring systems), Application (Single-vessel, Multi-vessel), Disease (Cardiology, Coronary Artery Disease) Players ...
$ 3500
Generic Sterile Injectable Comprehensive Study by Type (Large Molecule Injectable {Monoclonal Antibodies (Mab), Insulin, And Others}, Small Molecule Injectable), Application (Oncology, Infectious Dis...
$ 3750